---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-26-002901"
form_type: "8-K"
ticker: "MXCT"
cik: "0001287098"
company_name: "MAXCYTE, INC."
filed_at: "2026-01-12T23:59:59+00:00"
generated_at: "2026-05-16T10:47:32.073343+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# MaxCyte reports preliminary FY2025 core revenue in-line with guidance

## Summary
- Core revenue Q4 2025 est. $6.6-6.7M; full year $29.5-29.6M.
- SPL program-related revenue Q4 $0.4-0.6M; full year $3.3-3.5M.
- Cash, equivalents & investments ~$155.6M at Dec 31, 2025.
- CEO cites challenging year, cost restructuring, expects revenue growth in H2 2026.
- Preliminary unaudited results; audited FY2025 results due March 2026.

## SEC filing metadata
- accession: 0001104659-26-002901
- form_type: 8-K
- ticker: MXCT
- cik: 0001287098
- company_name: MAXCYTE, INC.
- filed_at: 2026-01-12T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1287098/000110465926002901/0001104659-26-002901-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1287098/000110465926002901/mxct-20260112x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-26-002901
- JSON: https://secwatch.observer/filing/0001104659-26-002901.json
- Plain text: https://secwatch.observer/filing/0001104659-26-002901.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.